Edition:
United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

29.78CNY
12:29am EST
Change (% chg)

¥1.05 (+3.65%)
Prev Close
¥28.73
Open
¥29.80
Day's High
¥30.20
Day's Low
¥29.38
Volume
17,887,378
Avg. Vol
5,025,616
52-wk High
¥30.20
52-wk Low
¥18.09

Chart for

About

ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine... (more)

Overall

Beta: 0.79
Market Cap(Mil.): ¥27,229.85
Shares Outstanding(Mil.): 1,042.49
Dividend: 0.18
Yield (%): 0.69

Financials

  Industry Sector
P/E (TTM): -- 32.13 15.67
EPS (TTM): -- -- --
ROI: -- 15.10 34.62
ROE: -- 16.59 16.00

BRIEF-Zhejiang Huahai Pharmaceutical to invest in pharma industry park project

* Says it plans to invest in pharma industry park project with total investment at about 10 billion yuan ($1.50 billion)

Oct 29 2017

BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval

* Says it received approval for a kind of tablet, which is used for treatment of chronic hepatitis B, from U.S. Food and Drug Administration

Oct 13 2017

BRIEF-Zhejiang Huahai Pharmaceutical passes FDA approval

* Says it received approval for its production base of API from U.S Food and Drug Administration

Sep 27 2017

BRIEF-Zhejiang Huahai Pharmaceutical to use $30 mln to acquire shares of Eutilex

* Says co signs agreement to invest $30 million in Eutilex Co.,Ltd, which is mainly engaged in R&D of T cell therapy and antibody therapy products

Sep 05 2017

BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval

* Says it received FDA approval for Paroxetine Capsules from U.S Food and Drug Administration

Aug 22 2017

BRIEF-Zhejiang Huahai Pharma's prelim H1 net profit up 14.05 pct y/y

* Says preliminary H1 net profit up 14.05 percent y/y at 295.25 million yuan ($43.73 million)

Jul 26 2017

Earnings vs. Estimates